NCT03868345View on ClinicalTrials.gov

Speech Analysis in ALS Patients

CompletedOBSERVATIONAL
Enrollment

26

Participants

Timeline

Start Date

February 18, 2019

Primary Completion Date

April 30, 2021

Study Completion Date

April 30, 2021

Conditions
ALSAmyotrophic Lateral SclerosisLou Gehrig Disease
Trial Locations (1)

85013

Barrow Neurological Institute, Phoenix

All Listed Sponsors
collaborator

Arizona State University

OTHER

lead

Barrow Neurological Institute

OTHER

NCT03868345 - Speech Analysis in ALS Patients | Biotech Hunter | Biotech Hunter